Inova Schar Cancer Institute Partners with N-of-One to Support the Launch of Inova’s Molecular Tumor Board

  • Posted by Emily Haynes
  • On October 12, 2016
  • 0 Comments
N-of-One’s Clinical Interpretation and Clinical Trial Matching Provides Patient-Specific Treatment Strategies to Empower Inova’s Precision Medicine Program CONCORD, Mass., Oct. 12, 2016 – N-of-One, Inc., a precision medicine oncology decision support company, today announced a partnership with Inova Schar Cancer Institute (ISCI) to support its molecular tumor board, the first in the DC metro area to invite […]
Read More
BACK TO
TOP
LEARN
MORE